Citius Oncology, Inc. CTOR Payments to Acquire Intangible Assets

Payments to Acquire Intangible Assets at other companies

Westwood Holdings GroupWHG

$200K-80.0%

ADTRAN Holdings, Inc.ADTN

$8.44M-25.3%

RFL

Rafael Holdings, Inc.RFL

$8K—

Lightwave Logic, Inc.LWLG

$170.94K+273%

Solidion Technology, Inc.STI

$23.98K-40.3%

Franklin CoveyFC

$0—

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Operating cash flow-$3.8M-179%

Market cap$60.45M-74.7%

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Citius Oncology, Inc.'s payments to acquire intangible assets?: Citius Oncology, Inc. (CTOR) reported payments to acquire intangible assets of $600K in Q1 2026.
How has Citius Oncology, Inc.'s payments to acquire intangible assets changed year-over-year?: Citius Oncology, Inc.'s payments to acquire intangible assets decreased by 58.3% year-over-year, from $1.44M to $600K.